Kyverna Therapeutics, Inc. (KYTX) Tops Q3 EPS by 17c
Tweet
Share
E-mailGet Alerts KYTX Hot Sheet
Join SI Premium – FREE
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q3 EPS of ($0.85), $0.17 better than the analyst estimate of ($1.02).
For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
